
About Acrow India
Acrow India is a publicly listed company based in Nashik (India) founded in 1960. Inpatient and outpatient healthcare services are provided in multiple locations. The company has 2 employees. Its Indian entity Acrow India Limited reported revenue of βΉ11.57 Cr. Acrow India offers products and services including Cotton Yarns and Cotton Processing.
Company details
Acrow India was founded in 1960 and is headquartered in Nashik, India, within the healthcare sector. Inpatient and outpatient services are delivered across specialties including cardiology, oncology, and orthopedics. Diagnostic imaging, emergency care, and therapeutic treatments are offered, alongside support such as patient billing and financial assistance. Clinics are operated in various locations, with programs addressing conditions like diabetes management. Community health initiatives are also emphasized.
- Headquarters Nashik, India
- Employees 2
- Stage Public
- Website acrowindia.com
- Legal Name Acrow India Limited
- Market Cap₹57.73 Cr
ACROW · BSE
- Share Price₹937.00
+3.88% today
- Revenue₹9.97 Cr
FY 2025-26 · +207.7% YoY
- EBITDA−₹0.77 Cr
Margin -7.7%
- Net Profit₹0.44 Cr
FY 2025-26 · +229.4% YoY
- P/E (TTM)110.7x
P/B 2.5x
- Employee Count2
Associated legal entities of Acrow India
Acrow India operates through Acrow India Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Acrow India Limited Listed CIN L46411MH1960PLC011601 | Active | 10 Mar 1960 | Aurangabad, Maharashtra | ₹11.6 Cr | 4 | 8 | View details |
Products & Services of Acrow India
Acrow India offers a comprehensive portfolio of products and services, including Cotton Yarns and Cotton Processing.
Cotton yarns are manufactured and supplied for industrial applications
Cotton is processed and traded as part of agricultural activities
Board of directors of Acrow India Limited (Acrow India)
Acrow India Limited is the primary company behind Acrow India. The board of Acrow India Limited currently have 6 directors; the longest-serving is Gopal Agrawal, appointed in 2022. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gopal Agrawal DIN 02160569 | Managing Director | 19 Dec 2022 | 3 yrs 10 mo | Acrow India Limited |
| Shyam Agrawal DIN 02192098 | Whole-time director | 19 Dec 2022 | 3 yrs 10 mo | Acrow India Limited |
| Devinder Khurana DIN 00059707 | Director | 19 Dec 2022 | 3 yrs 10 mo | Acrow India Limited |
| Kashinath Ganapaty Iyer DIN 01195975 | Director | 19 Dec 2022 | 3 yrs 10 mo | Acrow India Limited |
| Sarika Abhijit Kulkarni DIN 07141926 | Director | 19 Dec 2022 | 3 yrs 10 mo | Acrow India Limited |
| Sanjay Trilokchand Agrawal DIN 03500067 | Whole-time director | 22 May 2023 | 3 yrs 5 mo | Acrow India Limited |
IPO & Listings of Acrow India
Acrow India is a publicly listed company on the BSE with ticker symbol ACROW in India, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date10 Sep 2001
- Listed onBSE: 513149
- Listed entityAcrow India Limited
- Exchange sectorProducer manufacturing
- ISININE950D01012
- Share price₹817.90 (-0.5% on the day) · 2026-10-14
- Market capitalisation₹52.6 Cr
- Price to earnings100.8
- EPS (diluted, trailing year)₹8.11
- Volume (last session)147
Financials of Acrow India
Exchange-reported figures of Acrow India Limited, the listed company behind Acrow India (BSE: ACROW).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 9.97 | 3.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue growth | +207.7% | - | - | - | - | - | - |
| EBITDA | (0.77) | (1.07) | (1.90) | (0.97) | (1.43) | (0.69) | (0.91) |
| EBITDA margin | -7.7% | -33.0% | - | - | - | - | - |
| Profit before tax | 0.60 | 1.18 | 0.61 | (0.04) | 1.11 | (0.33) | (0.25) |
| Net profit | 0.44 | (0.34) | 0.94 | (0.32) | (0.83) | (0.38) | (0.20) |
| Net profit margin | +4.4% | -10.5% | - | - | - | - | - |
| EPS (βΉ) | 6.73 | (13.76) | 16.01 | 0.29 | 13.44 | (2.18) | (4.71) |
| Balance sheet | |||||||
| Total assets | 22.83 | 22.40 | 23.28 | 22.25 | 22.25 | 21.37 | 21.51 |
| Net worth | 22.83 | 22.40 | 23.28 | 22.25 | 22.23 | 21.37 | 21.51 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 0.00 | 0.07 | 0.01 | 0.03 | 7.18 | 5.76 | 5.98 |
| Net working capital | 21.22 | 20.59 | 18.47 | 18.08 | 9.32 | 8.23 | 7.79 |
| Cash flow | |||||||
| Cash from operations | (3.47) | (0.78) | (0.82) | (1.01) | (0.60) | (0.64) | (0.65) |
| Cash from investing | 3.41 | 0.83 | 0.80 | (6.14) | 2.02 | 0.41 | 0.79 |
| Cash from financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.05) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.05 | 7.16 | 1.75 | 0.00 | 3.24 | 0.00 | 0.00 |
| Revenue growth (YoY) | - | -67.6% | - | - | - | - | - | - |
| Other income | 0.40 | 0.35 | 0.45 | 0.40 | 0.40 | 0.45 | 0.71 | 0.93 |
| Total expenses | 0.12 | 1.37 | 6.95 | 2.19 | 0.23 | 3.90 | 0.20 | 0.12 |
| EBITDA | (0.12) | (0.32) | 0.21 | (0.44) | (0.23) | (0.66) | (0.20) | (0.12) |
| EBITDA margin | - | -30.5% | +2.9% | -25.1% | - | -20.4% | - | - |
| Depreciation | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.07 | 0.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.22 | (0.03) | 0.60 | (0.10) | 0.11 | (0.26) | 0.44 | 0.75 |
| Tax | 0.05 | 0.00 | 0.16 | 0.00 | 0.02 | 0.01 | 0.04 | 1.90 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.05 | 7.16 | 1.75 | 0.00 | 3.24 | 0.00 | 0.00 |
| Revenue growth (YoY) | - | -67.6% | - | - | - | - | - | - |
| Other income | 0.40 | 0.35 | 0.45 | 0.40 | 0.40 | 0.45 | 0.71 | 0.93 |
| Total expenses | 0.12 | 1.37 | 6.95 | 2.19 | 0.23 | 3.90 | 0.20 | 0.12 |
| EBITDA | (0.12) | (0.32) | 0.21 | (0.44) | (0.23) | (0.66) | (0.20) | (0.12) |
| EBITDA margin | - | -30.5% | +2.9% | -25.1% | - | -20.4% | - | - |
| Depreciation | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.07 | 0.06 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.22 | (0.03) | 0.60 | (0.10) | 0.11 | (0.26) | 0.44 | 0.75 |
| Tax | 0.05 | 0.00 | 0.16 | 0.00 | 0.02 | 0.01 | 0.04 | 1.90 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 9.97 | 3.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue growth | +207.7% | - | - | - | - | - | - |
| Other income | 1.60 | 2.50 | 2.81 | 1.11 | 2.78 | 0.60 | 0.93 |
| Total expenses | 10.74 | 4.31 | 1.90 | 0.97 | 1.43 | 0.69 | 0.91 |
| Employee cost | 0.00 | 0.23 | 0.11 | 0.16 | 0.23 | 0.18 | 0.07 |
| EBITDA | (0.77) | (1.07) | (1.90) | (0.97) | (1.43) | (0.69) | (0.91) |
| EBITDA margin | -7.7% | -33.0% | - | - | - | - | - |
| Depreciation | 0.23 | 0.25 | 0.30 | 0.18 | 0.24 | 0.24 | 0.27 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.60 | 1.18 | 0.61 | (0.04) | 1.11 | (0.33) | (0.25) |
| Tax | 0.16 | 2.04 | (0.42) | (0.07) | 0.25 | (0.18) | 0.05 |
| Net profit | 0.44 | (0.34) | 0.94 | (0.32) | (0.83) | (0.38) | (0.20) |
| Net profit margin | +4.4% | -10.5% | - | - | - | - | - |
| EPS (βΉ) | 6.73 | (13.76) | 16.01 | 0.29 | 13.44 | (2.18) | (4.71) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Reserves & surplus | 22.19 | 21.76 | 22.64 | 21.61 | 21.59 | 20.73 | 20.87 |
| Shareholders' funds (net worth) | 22.83 | 22.40 | 23.28 | 22.25 | 22.23 | 21.37 | 21.51 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 22.83 | 22.40 | 23.28 | 22.25 | 22.25 | 21.37 | 21.51 |
| Assets | |||||||
| Gross block | 5.18 | 5.58 | 7.61 | 8.49 | 9.01 | 11.29 | 11.29 |
| Net block | 2.15 | 2.41 | 3.53 | 3.87 | 3.98 | 4.02 | 4.26 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 8.95 | 8.99 | 9.25 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 | 0.66 |
| Sundry debtors | 0.09 | 3.40 | 0.00 | 0.00 | 0.15 | 0.14 | 0.04 |
| Cash & bank balances | 0.00 | 0.07 | 0.01 | 0.03 | 7.18 | 5.76 | 5.98 |
| Loans & advances | 21.58 | 22.00 | 18.99 | 18.10 | 2.07 | 1.75 | 1.22 |
| Total current assets | 21.67 | 25.47 | 19.00 | 18.13 | 9.40 | 8.31 | 7.90 |
| Total current liabilities | 0.45 | 4.88 | 0.53 | 0.05 | 0.08 | 0.08 | 0.11 |
| Net working capital | 21.22 | 20.59 | 18.47 | 18.08 | 9.32 | 8.23 | 7.79 |
| Total assets | 22.83 | 22.40 | 23.28 | 22.25 | 22.25 | 21.37 | 21.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.07 | 0.01 | 0.03 | 7.18 | 5.76 | 5.98 | 5.89 |
| Net cash from operating activities | (3.47) | (0.78) | (0.82) | (1.01) | (0.60) | (0.64) | (0.65) |
| Net cash from investing activities | 3.41 | 0.83 | 0.80 | (6.14) | 2.02 | 0.41 | 0.79 |
| Net cash from financing activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.05) |
| Net change in cash | (0.06) | 0.06 | (0.02) | (7.15) | 1.42 | (0.23) | 0.09 |
| Closing cash | 0.00 | 0.07 | 0.01 | 0.03 | 7.18 | 5.76 | 5.98 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +207.7% | - | - | - | - | - | - |
| EBITDA growth | +28.0% | +43.7% | -95.9% | +32.2% | -107.3% | +24.2% | - |
| PBT growth | -49.2% | +93.4% | +9998.0% | - | +9998.0% | -32.0% | - |
| Net income growth | +229.4% | -136.2% | +393.8% | +61.5% | -118.4% | -90.0% | - |
| Revenue CAGR (3Y) | - | - | - | - | - | - | -100.0% |
| EBITDA CAGR (3Y) | -7.4% | -9.2% | +40.2% | +2.2% | +26.9% | -14.7% | -7.5% |
| Profitability & leverage | |||||||
| Net income margin | +4.4% | -26.5% | - | - | - | - | - |
| Return on capital employed | - | +2.1% | +2.0% | -1.8% | -3.8% | -2.6% | -0.7% |
| Return on net worth | - | -1.6% | +4.1% | -1.5% | -3.8% | -1.7% | -0.9% |
| Debt / equity | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | - | 1.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (βΉ) | 6.73 | (13.76) | 16.01 | 0.29 | 13.44 | (2.18) | (4.71) |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 0.00 | 349.94 | 363.70 | 347.70 | 347.41 | 333.97 | 336.16 |
Web traffic of Acrow India
The website of Acrow India (acrowindia.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 48.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acrow India
Complete news archive for Acrow India
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acrow India
Acrow India was founded in 1960.
Acrow India is headquartered in Nashik, India. It is registered at Nashik, Maharashtra, India.
Acrow India has 2 employees.
The primary company behind Acrow India, Acrow India Limited, reported revenue of βΉ11.57 Cr for FY 2026, up 208% year on year.
Acrow India was founded in 1960 and is headquartered in Nashik, India, within the healthcare sector. Inpatient and outpatient services are delivered across specialties including cardiology, oncology, and orthopedics. Diagnostic imaging, emergency care, and therapeutic treatments are offered, alongside support such as patient billing and financial assistance. Clinics are operated in various locations, with programs addressing conditions like diabetes management. Community health initiatives are also emphasized.
Acrow India offers Cotton Yarns and Cotton Processing.
Yes, Acrow India is publicly traded on BSE under the ticker symbol ACROW.
Acrow India operates through Acrow India Limited.
The legal entities of Acrow India currently have 8 directors, including Gopal Agrawal, Shyam Agrawal, Devinder Khurana and others.
